Boehringer Ingelheim International GmbH | diagnosia.com

Boehringer Ingelheim International GmbH

Address: -
Telephone: -
Fax: -
Web: -
Email: -
Corporate Phone: -

For Pharmacy Companies

Get your Diagnosia.com profile and a presence on europe's leading medical drug search.

Logo Upload your logo
Contact details Your full contact details
Branding Let your CI do the talking
Newsfeed Integrate your corporate news

More Information

Drugs produced by Boehringer Ingelheim International GmbH

APTIVUS 100 mg/ml oral solution
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: J05AE09
APTIVUS 250 mg soft capsules
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: J05AE09
BEROMUN 1 mg/5 ml powder and solvent for solution for infusion
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: L03AX11
- Therapeutic Area: Sarcoma
- Active Substance: Tasonermin
Metalyse 10,000 units. Powder and solvent for solution for injection
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: B01AD11
- Active Substance: Tenecteplase
Metalyse 6,000 units. Powder and solvent for solution for injection
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: B01AD11
- Active Substance: Tenecteplase
Metalyse 8,000 units. Powder and solvent for solution for injection
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: B01AD11
- Active Substance: Tenecteplase
Micardis 20 mg tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: C09CA07
- Therapeutic Area: Hypertension
- Active Substance: Telmisartan
Micardis 40 mg tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: C09CA07
- Therapeutic Area: Hypertension
- Active Substance: Telmisartan
Micardis 80 mg tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: C09CA07
- Therapeutic Area: Hypertension
- Active Substance: Telmisartan
MicardisPlus 40 mg/12.5 mg tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: C09DA07
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Telmisartan
MicardisPlus 80 mg/12.5 mg tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: C09DA07
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Telmisartan
MicardisPlus 80 mg/25 mg tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: C09DA07
- Therapeutic Area: Hypertension
- Active Substance: Hydrochlorothiazide, Telmisartan
MIRAPEXIN 0.088 mg tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: N04BC05
- Therapeutic Area: Restless Legs Syndrome
- Active Substance: Pramipexole Dihydrochloride Monohydrate
MIRAPEXIN 0.18 mg tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: N04BC05
- Therapeutic Area: Restless Legs Syndrome
- Active Substance: Pramipexole Dihydrochloride Monohydrate
MIRAPEXIN 0.26 mg prolonged-release tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: N04BC05
- Therapeutic Area: Restless Legs Syndrome
- Active Substance: Pramipexole Dihydrochloride Monohydrate
MIRAPEXIN 0.35 mg tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: N04BC05
- Therapeutic Area: Restless Legs Syndrome
- Active Substance: Pramipexole Dihydrochloride Monohydrate
MIRAPEXIN 0.52 mg prolonged-release tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: N04BC05
- Therapeutic Area: Restless Legs Syndrome
- Active Substance: Pramipexole Dihydrochloride Monohydrate
MIRAPEXIN 0.7 mg tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: N04BC05
- Therapeutic Area: Restless Legs Syndrome
- Active Substance: Pramipexole Dihydrochloride Monohydrate
MIRAPEXIN 1.05 mg prolonged-release tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: N04BC05
- Therapeutic Area: Restless Legs Syndrome
- Active Substance: Pramipexole Dihydrochloride Monohydrate
MIRAPEXIN 1.1 mg tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: N04BC05
- Therapeutic Area: Restless Legs Syndrome
- Active Substance: Pramipexole Dihydrochloride Monohydrate
MIRAPEXIN 1.57 mg prolonged-release tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: N04BC05
- Therapeutic Area: Restless Legs Syndrome
- Active Substance: Pramipexole Dihydrochloride Monohydrate
MIRAPEXIN 2.1 mg prolonged-release tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: N04BC05
- Therapeutic Area: Restless Legs Syndrome
- Active Substance: Pramipexole Dihydrochloride Monohydrate
MIRAPEXIN 2.62 mg prolonged-release tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: N04BC05
- Therapeutic Area: Restless Legs Syndrome
- Active Substance: Pramipexole Dihydrochloride Monohydrate
MIRAPEXIN 3.15 mg prolonged-release tablets
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: N04BC05
- Therapeutic Area: Restless Legs Syndrome
- Active Substance: Pramipexole Dihydrochloride Monohydrate
Pradaxa 110 mg hard capsules
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: B01AE07
Pradaxa 75 mg hard capsules
- admission:
  Great Britain
- Producer: Boehringer Ingelheim International GmbH
- ATC-Code: B01AE07

Pages